Medprin Regenerative Medical Technologies Balance Sheet Health
Financial Health criteria checks 5/6
Medprin Regenerative Medical Technologies has a total shareholder equity of CN¥663.3M and total debt of CN¥1.3M, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are CN¥744.5M and CN¥81.2M respectively. Medprin Regenerative Medical Technologies's EBIT is CN¥76.0M making its interest coverage ratio -18.7. It has cash and short-term investments of CN¥180.1M.
Key information
0.2%
Debt to equity ratio
CN¥1.32m
Debt
| Interest coverage ratio | -18.7x |
| Cash | CN¥180.11m |
| Equity | CN¥663.27m |
| Total liabilities | CN¥81.20m |
| Total assets | CN¥744.47m |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301033's short term assets (CN¥285.9M) exceed its short term liabilities (CN¥45.1M).
Long Term Liabilities: 301033's short term assets (CN¥285.9M) exceed its long term liabilities (CN¥36.1M).
Debt to Equity History and Analysis
Debt Level: 301033 has more cash than its total debt.
Reducing Debt: 301033's debt to equity ratio has increased from 0% to 0.2% over the past 5 years.
Debt Coverage: 301033's debt is well covered by operating cash flow (7577.4%).
Interest Coverage: 301033 earns more interest than it pays, so coverage of interest payments is not a concern.